Navigation Links
Accuray Establishes Medical Affairs Function
Date:12/17/2010

SUNNYVALE, Calif., Dec. 17, 2010 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that the company has established a Medical Affairs function to accelerate CyberKnife data collection, utilization and referral patterns and to provide strategic guidance on clinically driven processes, innovations and initiatives.

Since the company's inception in 1990, Accuray has been focused on driving innovation that meets the unique needs of clinicians and patients as part of its corporate strategy to improve patient care across various cancers and indications. With more than 500 peer-reviewed publications supporting the use of CyberKnife radiosurgery, Medical Affairs will continue to further medical research through the development and support of clinical studies and protocols globally, while also strengthening relationships with key opinion leaders and academic centers worldwide.

"We are very proud to announce the formation of Medical Affairs, which demonstrates another positive step in our ongoing strategy toward clinically driven research and development, innovation and customer support," said Euan S. Thomson, Ph.D., president and CEO of Accuray. "Because we are changing clinical practice, we believe this function will play a vital part in supporting our customers in their adoption, utilization and medical research and will be pivotal in helping establish the clinical applications of the future."

Omar Dawood, M.D., M.P.H, a surgeon and radiologist by training who has led Accuray's Clinical Development team over the past three and a half years, will lead the Medical Affairs function, and will report in to Euan Thomson, Accuray's CEO. The organization will focus on understanding the needs of clinicians worldwide and supporting their efforts to advance the field of radiosurgery and improve patient care.  

About the CyberKnife® Robotic Radiosurgery System

The CyberKnife Robotic Radiosurgery System is the world's only robotic radiosurgery system designed to treat tumors anywhere in the body non-invasively. Using continual image guidance technology and computer controlled robotic mobility, the CyberKnife System automatically tracks, detects and corrects for tumor and patient movement in real-time throughout the treatment. This enables the CyberKnife System to deliver high-dose radiation with pinpoint precision, which minimizes damage to surrounding healthy tissue and eliminates the need for invasive head or body stabilization frames.

About Accuray

Accuray Incorporated (Nasdaq: ARAY), based in Sunnyvale, Calif., is a global leader in the field of radiosurgery dedicated to providing an improved quality of life and a non-surgical treatment option for those diagnosed with cancer. Accuray develops and markets the CyberKnife Robotic Radiosurgery System, which extends the benefits of radiosurgery to include extracranial tumors, including those in the spine, lung, prostate, liver and pancreas. To date, the CyberKnife System has been used to treat more than 100,000 patients worldwide and currently more than 215 systems have been installed in leading hospitals in the Americas, Europe and Asia. For more information, please visit www.accuray.com.

Safe Harbor Statement

The foregoing may contain certain forward-looking statements that involve risks and uncertainties, including uncertainties associated with the medical device industry. Except for the historical information contained herein, the matters set forth in this press release, including statements relating to market acceptance and clinical acceptance are forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements speak only as of the date the statements are made and are based on information available at the time those statements are made and/or management's good faith belief as of that time with respect to future events. You should not put undue reliance on any forward-looking statements. Important factors that could cause actual performance and results to differ materially from the forward-looking statements we make include: market acceptance of products, clinical acceptance and other risks detailed from time to time under the heading "Risk Factors" in our report on Form 10-K for our 2010 fiscal year, our form 10-Q filed on November 8, 2010 and our other filings with the Securities and Exchange Commission. The Company's actual results of operations may differ significantly from those contemplated by such forward-looking statements as a result of these and other factors. We assume no obligation to update forward-looking statements to reflect actual performance or results, changes in assumptions or changes in other factors affecting forward-looking information, except to the extent required by applicable securities laws.

Available Topic Expert(s): For information on the listed expert(s), click appropriate link.

Omar Dawood, M.D., MPH

https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=85068


'/>"/>
SOURCE Accuray Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Accuray Incorporated to Report Financial Results for First Quarter of Fiscal 2010
2. Accuray Incorporated to Present at 20th Annual Oppenheimer Healthcare Conference
3. Accuray Ranked 155th Fastest Growing Company in North America on Deloittes 2009 Technology Fast 500(TM)
4. Accuray Announces Regionalized Management Strategy for Americas
5. Accurays Treatment Planning Service Active at 20 Percent of U.S. CyberKnife Centers
6. Accuray Introduces the CyberKnife(R) VSI(TM) System
7. Accuray Announces Results for Second Quarter Fiscal 2010
8. Accuray Incorporated to Report Financial Results for Second Quarter of Fiscal 2010
9. Accuray Hires General Manager for Japan
10. Accuray Incorporated to Present at 28th Annual J. P. Morgan Healthcare Conference
11. Accuray Incorporated to Present at Piper Jaffray Healthcare Conference and J. P. Morgan Small/Mid Cap Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... --  Bernstein Liebhard LLP today announced that a securities ... Court for the District of Arizona ... persons or entities who purchased common shares of Insys Therapeutics ... March 3, 2015 through January 25, 2016 (the "Class Period").  ... violations of the Securities Exchange Act of 1934.  ...
(Date:2/4/2016)... 4, 2016  Montoya Love is recognized by Continental ... of Pharmaceuticals. Montoya is the Regulatory Systems Operations Manager ... Manufacturing and selling a broad ... provides healthcare institutions, clinical laboratories and life science ... across the globe. ...
(Date:2/4/2016)... , Feb. 4, 2016 Frontier Pharma: ... Commercializing First-in-Class Innovation Chronic Obstructive ... with chronic inflammation of the airways and lungs. ... symptoms make the disease one of the leading ... death in the world. COPD is linked to ...
Breaking Medicine Technology:
(Date:2/7/2016)... ... 2016 , ... Dr. Todd Hobgood , certificated in ... surgical expertise. Technically known as deoxycholic acid or previously as ATX-101, Kybella® ... for reduction of fat below the chin (aka the “double chin”). Medication side ...
(Date:2/6/2016)... ... , ... With the FCPX LUT: Summer pack from Pixel Film ... LUT is a Lookup Table that contains a mathematical formula for modifying an image. ... By manipulating each pixel, LUT's can change each color range differently, it gives the ...
(Date:2/5/2016)... ... February 05, 2016 , ... Steven Tonkinson, 36, of ... completed every year since it started in 2003. This year, he ran all 26.2 ... fellow runners and NBA team the Miami Heat. , This Sunday, while many are ...
(Date:2/5/2016)... ... February 05, 2016 , ... Today, the Whole-Food Warrior TV show, hosted ... feature with author Jahnavi Foster, specialist in healthy vegetarian cuisine, will stream on Friday, ... on his weekly Whole-Food Warrior TV show, Frank Davis highlights Whole-Food Warriors - people ...
(Date:2/5/2016)... ... February 05, 2016 , ... The Muscular Dystrophy ... Kitchen restaurants, launched the 14th annual “Appetite for a Cure” campaign on Feb. ... dystrophy, ALS and related diseases that severely limit strength and mobility. , ...
Breaking Medicine News(10 mins):